Dupuytren Contracture Clinical Trials 2023

What are the top hospitals conducting dupuytren contracture research?

When it comes to clinical trials for dupuytren contracture, two hospitals stand out in their dedication to finding breakthrough treatments for this condition. In Tampa, Florida Orthopaedic Institute is leading the way with one ongoing trial focused on dupuytren contracture. This hospital has also recorded one previous trial in its pursuit of understanding and treating this hand deformity. The institute's commitment to advancing research in this field is evident as they initiated their first-ever dupuytren contracture trial just last year in 2021.

In Rochester, Mayo Clinic is another institution making significant strides in the realm of dupuytren contracture research. Currently, they have one active clinical trial dedicated to studying and improving outcomes for patients affected by this condition. The clinic's journey into addressing dupuytren contracture began back in 2016 when they conducted their initial trial.

Dupuytren contracture, a fascinating but often misunderstood condition affecting the connective tissue beneath the skin of the palm and fingers, can cause debilitating finger flexion deformities over time. It primarily affects individuals of Northern European descent and tends to run in families. Despite being a relatively common ailment that impacts millions worldwide, effective treatment options have been limited until now.

The efforts undertaken by these hospitals demonstrate not only their commitment but also the collective determination within the medical community to find new solutions for those affected by this challenging hand disorder. As researchers continue exploring innovative approaches through clinical trials like these, hope shines brightly for improved therapies that may ultimately alleviate pain and restore functionality among individuals living with du

Which are the best cities for dupuytren contracture clinical trials?

When it comes to clinical trials for Dupuytren contracture, two cities emerge as leaders in research and development. Tampa, Florida, currently has 1 active trial focusing on the No Splint Group intervention among others. Rochester, Minnesota, also offers 1 ongoing trial exploring treatments like Division/manipulation of the cord and more. These cities provide individuals with Dupuytren contracture access to cutting-edge clinical trials that investigate potential breakthroughs in care for this condition.

Which are the top treatments for dupuytren contracture being explored in clinical trials?

Clinical trials are actively exploring various treatments for Dupuytren contracture, with one standout option being the division/manipulation of the cord. This technique is currently being tested in a single active trial dedicated to Dupuytren contracture and has been listed since 2016. Researchers are carefully evaluating its effectiveness and potential benefits for patients suffering from this condition. As these trials progress, we gain valuable insights into new treatment possibilities that could improve the lives of individuals affected by Dupuytren contracture.

What are the most recent clinical trials for dupuytren contracture?

In the realm of dupuytren contracture, recent clinical trials have shed light on potential advancements in treatment options. One notable trial focused on a no splint group approach, which has reached Phase 3 and became available as of July 12th, 2021. This innovative study aims to explore alternative strategies for managing this condition by investigating the effectiveness of treatments that do not involve traditional splints. By pushing beyond conventional methods, these trials strive to bring about improved outcomes and enhanced quality of life for those affected by dupuytren contracture.

What dupuytren contracture clinical trials were recently completed?

Recently completed clinical trials have made significant strides in the understanding and treatment of Dupuytren's contracture. Notably, a trial sponsored by CollPlant Biotechnologies investigated the effectiveness of rhCollagen combined with mitomycin C, demonstrating promising results. Additionally, a separate trial conducted by BioSpecifics Technologies evaluated collagenase clostridium histolyticum as a potential therapy for this debilitating condition. These recently completed trials shed light on new approaches to managing Dupuytren's contracture and offer hope for improved outcomes for patients affected by this condition.